Aizhang Xu

575 citations

19 papers · 389 indexed · h-index 12

Co-authors: Jim Xiang Andrew Freywald Rajni Chibbar Xin TanJie WuRongxiu Li Qin Zhao Yulin Deng
Topics: Immunotherapy and Immune Responses (10 papers)Immune Cell Function and Interaction (8 papers)CAR-T cell therapy research (5 papers)
Cited by: Aging Immunology Oncology
Journals: The Journal of Immunology PLoS ONE Scientific Reports
Partner nations: China Canada United States

In The Last Decade

Aizhang Xu

18 papers receiving 384 citations

Peers

Countries citing papers authored by Aizhang Xu

Since Specialization

Citations

This map shows the geographic impact of Aizhang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aizhang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aizhang Xu more than expected).

Fields of papers citing papers by Aizhang Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aizhang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aizhang Xu. The network helps show where Aizhang Xu may publish in the future.

Co-authorship network of co-authors of Aizhang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Aizhang Xu. A scholar is included among the top collaborators of Aizhang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aizhang Xu. Aizhang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Regulatory T Cells in Invasive Breast Cancer: Prognosis, Mechanisms and Therapy 2025 ·Cancers ·Aizhang Xu,(unknown),Haijun Zhang,(unknown),(unknown),Xiaojing Ma	0
2	Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis 2023 ·International Journal of Cancer ·(unknown),Xue Dong,Mei Song,Aizhang Xu,Qing He,Huilin Li,(unknown),Lotfi Chouchane,Xiaojing Ma	7
3	The Critical Role of AMPKα1 in Regulating Autophagy and Mitochondrial Respiration in IL-15-Stimulated mTORC1Weak Signal-Induced T Cell Memory: An Interplay between Yin (AMPKα1) and Yang (mTORC1) Energy Sensors in T Cell Differentiation 2022 ·International Journal of Molecular Sciences ·Anjuman Ara,Zhaojia Wu,Aizhang Xu,Khawaja Ashfaque Ahmed,Scot C. Leary,(unknown),Rajni Chibbar,Yue Wu,Jim Xiang	7
4	Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors 2021 ·Cellular and Molecular Immunology ·(unknown),Jiangbo Wan,Aizhang Xu,Zhaojia Wu,Shahid Ahmed,Andrew Freywald,Rajni Chibbar,Yue Wu,Mike Moser,Gary Groot,Wenjun Zhang,Bing Zhang,Jim Xiang	31
5	Prosurvival IL-7–Stimulated Weak Strength of mTORC1-S6K Controls T Cell Memory via Transcriptional FOXO1–TCF1–Id3 and Metabolic AMPKα1–ULK1–ATG7 Pathways 2021 ·The Journal of Immunology ·Aizhang Xu,Scot C. Leary,(unknown),Zhaojia Wu,Kalpana K. Bhanumathy,Anjuman Ara,Rajni Chibbar,(unknown),Khawaja Ashfaque Ahmed,Jim Xiang	13
6	The Energy Sensor AMPKα1 Is Critical in Rapamycin-Inhibition of mTORC1-S6K-Induced T-cell Memory 2021 ·International Journal of Molecular Sciences ·Anjuman Ara,Aizhang Xu,Khawaja Ashfaque Ahmed,Scot C. Leary,(unknown),Zhaojia Wu,Rajni Chibbar,Jim Xiang	12
7	Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice 2018 ·Vaccine ·Yufeng Xie,Jie Wu,Aizhang Xu,(unknown),Amer Sami,Rajni Chibbar,Andrew Freywald,Changyu Zheng,Jim Xiang	25
8	Simulated microgravity inhibits cell focal adhesions leading to reduced melanoma cell proliferation and metastasis via FAK/RhoA-regulated mTORC1 and AMPK pathways 2018 ·Scientific Reports ·Xin Tan,Aizhang Xu,Tuo Zhao,Qin Zhao,Jun Zhang,Cuihong Fan,Yulin Deng,Andrew Freywald,Harald Genth,Jim Xiang	67
9	TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis 2018 ·Cellular and Molecular Immunology ·Aizhang Xu,Lifeng Zhang,(unknown),(unknown),Andrew Freywald,Rajni Chibbar,Mike Moser,Wenjun Zhang,Bing Zhang,(unknown),Jim Xiang	51
10	Transgene IL-21-Engineered T Cell-Based Vaccine Potently Converts CTL Exhaustion via the Activation of the mTORC1 Pathway in Chronic Infection 2018 ·Aizhang Xu,Xueying Zhang,Rajni Chibbar,Andrew Freywald,Suresh K. Tikoo,Changyu Zheng,Jim Xiang	2
11	Simulated Microgravity Reduces Focal Adhesions and Alters Cytoskeleton and Nuclear Positioning Leading to Enhanced Apoptosis via Suppressing FAK/RhoA-Mediated mTORC1/NF-κB and ERK1/2 Pathways 2018 ·International Journal of Molecular Sciences ·Tuo Zhao,Rong Li,Xin Tan,Jun Zhang,Cuihong Fan,Qin Zhao,Yulin Deng,Aizhang Xu,Kiven Erique Lukong,Harald Genth,Jim Xiang	41
12	CD40 agonist converting CTL exhaustion via the activation of the mTORC1 pathway enhances PD-1 antagonist action in rescuing exhausted CTLs in chronic infection 2017 ·Biochemical and Biophysical Research Communications ·Aizhang Xu,(unknown),Andrew Freywald,(unknown),Suresh K. Tikoo,Jianqing Xu,Changyu Zheng,Jim Xiang	8
13	Enhanced suppression of polyclonal CD8+25+ regulatory T cells via exosomal arming of antigen-specific peptide/MHC complexes 2017 ·Journal of Leukocyte Biology ·Chuanyong Mu,Xueshu Zhang,Lu Wang,Aizhang Xu,Khawaja Ashfaque Ahmed,Xueqin Pang,Rajni Chibbar,Andrew Freywald,Jianan Huang,Yehan Zhu,Jim Xiang	17
14	Immunogenicity and efficacy of a rationally designed vaccine against vascular endothelial growth factor in mouse solid tumor models 2016 ·Cancer Immunology Immunotherapy ·Aizhang Xu,Li Zhang,Yang‐Yang Chen,(unknown),Rongxiu Li	16
15	Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway 2016 ·Cellular and Molecular Immunology ·Rong Wang,Aizhang Xu,Xueying Zhang,Jie Wu,Andrew Freywald,Jianqing Xu,Jim Xiang	32
16	IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia 2016 ·Cell & Bioscience ·Aizhang Xu,Kalpana K. Bhanumathy,Jie Wu,Zhenmin Ye,Andrew Freywald,Scot C. Leary,Rongxiu Li,Jim Xiang	26
17	A Rationally Designed TNF-α Epitope-Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen-Induced Arthritis in Mice 2016 ·PLoS ONE ·Li Zhang,Jin Wang,Aizhang Xu,(unknown),Wuguang Lu,Li Deng,Rongxiu Li	18
18	Potent immunotherapy against well‐established thymoma using adoptively transferred transgene IL‐6‐engineered dendritic cell‐stimulated CD8⁺ T‐cells with prolonged survival and enhanced cytotoxicity 2015 ·The Journal of Gene Medicine ·Kalpana K. Bhanumathy,Bei Zhang,Yufeng Xie,Aizhang Xu,Xin Tan,Jim Xiang	5
19	Design and synthesis of affinity ligands and relation of their structure with adsorption of proteins 2011 ·Journal of Separation Science ·Long Ye,Aizhang Xu,Chao Cheng,Li Zhang,(unknown),(unknown),Hong Xu,Rongxiu Li	11

About Aizhang Xu

Aizhang Xu is a scholar working on Immunology, Oncology and Physiology, having authored 19 papers that have together received 389 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (8 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Aging (35 citations), Immunology (157 citations) and Oncology (102 citations). Aizhang Xu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Jim Xiang, Andrew Freywald, Rajni Chibbar, Xin Tan, Jie Wu, Rongxiu Li, Qin Zhao, Yulin Deng, Tuo Zhao and Cuihong Fan. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact